Literature DB >> 18789835

MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin.

Tao Liu1, Hua Tang, Yuanyuan Lang, Min Liu, Xin Li.   

Abstract

MicroRNAs (miRNAs) may function as oncogenes or tumor suppressors. Here, we show that miR-27a is up-regulated in human gastric adenocarcinoma. Suppression of miR-27a inhibits gastric cancer cell growth. Subsequently, prohibitin is identified as a potential miR-27a target, combining bioinformatics and microarray analysis. EGFP report experiment also confirms that the 3' untranslated region (3'UTR) of prohibitin carries the directly binding site of miR-27a. After knockdown of miR-27a in gastric cancer cells, mRNA level and protein level of prohibitin are both elevated. Down-regulation of prohibitin by miR-27a may explain why suppression of miR-27a can inhibit gastric cancer cell growth, further supporting that miR-27a functions as an oncogene.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18789835     DOI: 10.1016/j.canlet.2008.08.003

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  147 in total

1.  MicroRNA-590-5p regulates proliferation and invasion in human hepatocellular carcinoma cells by targeting TGF-β RII.

Authors:  Xiaofeng Jiang; Guangyang Xiang; Yezeng Wang; Lei Zhang; Xuewei Yang; Liangqi Cao; Heping Peng; Ping Xue; De Chen
Journal:  Mol Cells       Date:  2012-06-07       Impact factor: 5.034

Review 2.  MicroRNAs: novel biomarkers for gastrointestinal carcinomas.

Authors:  Li Xie; Xiaoping Qian; Baorui Liu
Journal:  Mol Cell Biochem       Date:  2010-04-27       Impact factor: 3.396

3.  A network connecting Runx2, SATB2, and the miR-23a~27a~24-2 cluster regulates the osteoblast differentiation program.

Authors:  Mohammad Q Hassan; Jonathan A R Gordon; Marcio M Beloti; Carlo M Croce; Andre J van Wijnen; Janet L Stein; Gary S Stein; Jane B Lian
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-27       Impact factor: 11.205

4.  MicroRNA-592 targets DEK oncogene and suppresses cell growth in the hepatocellular carcinoma cell line HepG2.

Authors:  Xin Li; Wenfeng Zhang; Liya Zhou; Donghui Yue; Xin Su
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

5.  Cross-talk between MET and EGFR in non-small cell lung cancer involves miR-27a and Sprouty2.

Authors:  Mario Acunzo; Giulia Romano; Dario Palmieri; Alessandro Laganá; Michela Garofalo; Veronica Balatti; Alessandra Drusco; Mario Chiariello; Patrick Nana-Sinkam; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-06       Impact factor: 11.205

6.  Prohibitin Interacts with envelope proteins of white spot syndrome virus and prevents infection in the red swamp crayfish, Procambarus clarkii.

Authors:  Jiang-Feng Lan; Xin-Cang Li; Jie-Jie Sun; Jing Gong; Xian-Wei Wang; Xiu-Zhen Shi; Li-Jie Shi; Yu-Ding Weng; Xiao-Fan Zhao; Jin-Xing Wang
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

7.  Down-regulation of miR-27a might reverse multidrug resistance of esophageal squamous cell carcinoma.

Authors:  Hongwei Zhang; Mengbin Li; Yu Han; Liu Hong; Taiqian Gong; Li Sun; Xiushan Zheng
Journal:  Dig Dis Sci       Date:  2009-12-04       Impact factor: 3.199

Review 8.  Cooperative and individualistic functions of the microRNAs in the miR-23a~27a~24-2 cluster and its implication in human diseases.

Authors:  Ravindresh Chhabra; Richa Dubey; Neeru Saini
Journal:  Mol Cancer       Date:  2010-09-03       Impact factor: 27.401

9.  Manipulating prohibitin levels provides evidence for an in vivo role in androgen regulation of prostate tumours.

Authors:  D Alwyn Dart; Bradley Spencer-Dene; Simon C Gamble; Jonathan Waxman; Charlotte L Bevan
Journal:  Endocr Relat Cancer       Date:  2009-07-27       Impact factor: 5.678

10.  Regulation of the transcription factor NF-kappaB1 by microRNA-9 in human gastric adenocarcinoma.

Authors:  Hai-Ying Wan; Li-Min Guo; Tao Liu; Min Liu; Xin Li; Hua Tang
Journal:  Mol Cancer       Date:  2010-01-26       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.